查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1919406

农业合成生物学市场按产品类型、技术平台、配方、应用领域和最终用户划分－2026年至2032年全球预测

Agriculture Synthetic Biology Market by Product Type, Technology Platform, Formulation, Application Area, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，农业合成生物学市场价值将达到 124.9 亿美元，到 2026 年将成长至 131.5 亿美元，到 2032 年将达到 183.2 亿美元，复合年增长率为 5.61%。

关键市场统计数据
基准年 2025 124.9亿美元
预计年份：2026年 131.5亿美元
预测年份 2032 183.2亿美元
复合年增长率 (%) 5.61%

技术、监管变革和商业化三者融合，共同开启了农业合成生物学的新时代，这将重新定义农业生产力和韧性。

农业合成生物学正在重塑相关人员对全球粮食和纤维系统生产力、永续性和韧性的认知。基因编辑、通路工程和生物製药的进步，使得在微生物学、植物生理学和生态学交叉领域发挥作用的解决方案成为可能。这些技术进步伴随着新的交付模式、合作商业化模式以及不断变化的监管环境，而这需要开发人员、生产者和政策制定者之间的跨学科合作。

识别技术采纳、商业化模式和交付系统的关键转折点，这些转折点将重新定义农业合成生物学价值链。

农业合成生物学领域正经历变革性的转变，涵盖技术成熟、商业化模式和生态系统整合等各个面向。精准基因编辑、模组化合成途径和标靶RNA干扰等技术平台正从实验室展示走向田间检验产品，从而改变现有的采购和应用模式。研发人员正将严谨的工程技术与农艺检验相结合，并促进生物技术公司、种子企业和大型种植者之间的合作，以在保持农艺性能的同时加速技术的应用。

评估美国2025年实施的累积关税如何重塑农业合成生物学领域的供应链、合作动态和商业化路径。

2025年美国关税政策为农业合成生物学相关的国际投入、合作研究和跨境商业化带来了新的摩擦。对原料、生物加工设备和某些半成品的关税，使依赖全球供应链获取酵素、生物反应器和製剂成分的製造商的采购流程变得更加复杂。这迫使供应链相关人员重新评估其筹资策略，尽可能优先考虑近岸外包，并评估库存缓衝方法以维持生产的连续性。

根据产品类别、应用、技术平台、最终用户和配方选择等方面的细分，确定策略要务，以指导投资和商业化决策。

基于细分市场的洞察揭示了产品、应用、技术、终端用户和配方方面的差异如何影响农业合成生物学领域的研发重点和商业化策略。根据产品类型，相关人员应区分以下几类：生物肥料（包括固氮菌株、溶磷菌株和钾动员菌株）、生质燃料（例如生物柴油、生质乙醇生物膜、生质塑胶）、生物农药（包括生化、微生物和RNAi方法）以及酵素（例如淀粉酶、纤维素酶和蛋白酶）。产品类型都有不同的研发週期、监管节点和通路，因此需要针对每类产品製定单独的上市计划。

描绘了区域监管趋势、行业能力和农业优先事项将如何影响美洲、欧洲、中东和非洲以及亚太地区的采用和商业化路径。

区域洞察揭示了需求驱动因素、法规结构和行业能力在不同地区的差异，以及这些差异如何影响开发商和投资者的策略重点。在美洲，成熟的农业供应链和充满活力的私人投资群体正在推动生物製剂的快速初步试验和商业化，这得益于其在发酵、酵素生产和精准应用技术方面的深厚实力。政策辩论和州级奖励也影响生物製剂的推广路径，基因编辑解决方案的接受度存在区域差异，并且越来越重视将永续性指标纳入采购流程。

检验了平台专业化、商业化伙伴关係以及生产规模化如何为农业合成生物学领域的公司创造差异化的竞争优势。

农业合成生物学领域的公司层面发展趋势呈现出平台专家、垂直整合型老牌企业和敏捷型新创公司并存的局面，这些公司致力于将研发成果转化为实际应用。主要企业强调模组化技术Start-Ups，以实现产品平臺的快速迭代；而新参与企业则倾向于专注于小众但影响深远的应用案例，以验证其有效性并建立市场影响力。产品开发商与以分销为导向的农业供应商之间的策略联盟，能够利用既有通路和种植者关係，加速产品进入市场。

为了加速合成生物学的采用并降低商业化风险，应优先考虑监管前瞻性、配方主导的产品设计、策略伙伴关係和供应链韧性。

产业领导者应采取切实可行的优先事项，协调研发、监管规划和商业执行，以加速产品推广并降低风险。首先，在产品开发初期就应考虑监管合规和管理，以缩短审批时间并建立市场信心。儘早与监管机构沟通并制定透明的环境监测计划，将有助于提高田间试验的可靠性，并促进后续的註册流程。其次，在菌株和分子开发的同时，推动製剂创新，以确保产品设计能体现给药性能和农场实际应用价值。

本分析采用混合方法分析方法，结合了初步访谈、文献综述、专利和监管审查以及专家检验，以确保得出可靠的结论。

本分析的调查方法结合了原始质性资料、二手文献综述和多学科专家检验，从而得出可靠且可操作的见解。原始数据包括对技术开发人员、配方科学家、农艺师、供应链营运人员和监管专家的结构化访谈。这些访谈提供了研发瓶颈、田间检验重点和商业化限制的第一手观点，为跨产品类型和应用的主题分析奠定了基础。

总之，我们认为，将平台开发、製剂科学、监管事务和商业化伙伴关係结合的策略将决定农业合成生物学的成功。

本结论整合了报告的诊断和咨询两方面内容。农业合成生物学正从概念验证创新阶段迈向商业性化解决方案阶段，需要跨技术、配方、监管和市场管道的整合策略。能够将平台功能与明确的应用需求相匹配、投资于可扩展的生产和供应系统、并积极与监管机构和农场层面的相关人员互动以建立信誉并减少推广障碍的机构，将更有可能取得成功。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按产品类型分類的农业合成生物学市场

  • 生物肥料
    • 固氮作用
    • 磷酸盐溶解
    • 钾溶解
  • 生质燃料
    • 生质柴油
    • 生质乙醇
  • 生医材料
    • 生物膜
    • 生质塑胶
  • 生物农药
    • 生化产品
    • 微生物製剂
    • 基于RNAi的
  • 酵素
    • 淀粉酶
    • 纤维素酶
    • 蛋白酶

9. 按技术平台分類的农业合成生物学市场

  • Crispr/Cas
    • 基地编辑
    • Cas12
    • Cas9
  • 代谢工程
    • 通量分析
    • 路线优化
  • RNAi干扰
    • miRna
    • siRNA
  • 合成路线
    • 模组化生物合成
    • 通路组装

10. 按配方分類的农业合成生物学市场

  • 封装
    • 微胶囊化
    • 奈米封装
  • 液体
    • 水溶液
    • 乳液
  • 粉末
    • 干颗粒
    • 可水合粉末

第十一章 按应用领域分類的农业合成生物学市场

  • 动物健康
    • 益生菌
    • 治疗性蛋白质
  • 作物保护
    • 疾病管制
    • 害虫防治
    • 除草
  • 促进生长
    • 根系发育
    • 抗压能力
    • 产量提升
  • 土壤修復
    • 重金属去除
    • 有机污染物的分解

12. 按最终用户分類的农业合成生物学市场

  • 农业生物技术公司
    • 现有公司
    • Start-Ups公司
  • 商业农场
    • 大规模
    • 小规模农户
  • 研究所
    • 政府研究机构
    • 大学

第十三章 农业合成生物学市场：按地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 农业合成生物学市场（依群体划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国农业合成生物学市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国农业合成生物学市场

第十七章 中国农业合成生物学市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AgBiome, Inc.
  • Agragene, Inc.
  • Arzeda Corporation
  • BASF SE
  • Bayer AG
  • Benson Hill, Inc.
  • BioConsortia, Inc.
  • Calysta, Inc.
  • Caribou Biosciences, Inc.
  • Conagen Inc.
  • Corteva, Inc.
  • DuPont de Nemours, Inc.
  • EVOLVE Biosystems, Inc.
  • Ginkgo Bioworks, Inc.
  • Inari Agriculture, Inc.
  • Indigo Agriculture, Inc.
  • KWS SAAT SE & Co. KGaA
  • Limagrain Group
  • Pairwise Companies, Inc.
  • Pivot Bio, Inc.
  • Syngenta AG
  • Synthace Ltd.
  • Zymergen Inc.
Product Code: MRR-F14BA1B3430B

The Agriculture Synthetic Biology Market was valued at USD 12.49 billion in 2025 and is projected to grow to USD 13.15 billion in 2026, with a CAGR of 5.61%, reaching USD 18.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.49 billion
Estimated Year [2026] USD 13.15 billion
Forecast Year [2032] USD 18.32 billion
CAGR (%) 5.61%

Framing the era of agricultural synthetic biology where technology, regulatory evolution, and commercialization converge to redefine productivity and resilience

Agricultural synthetic biology is reshaping the way stakeholders conceive of productivity, sustainability, and resilience across global food and fiber systems. Advances in gene editing, pathway assembly, and biologics formulation are enabling solutions that operate at the interface of microbiology, plant physiology, and agroecology. These technological strides are accompanied by new delivery formats, collaborative commercialization models, and an evolving regulatory landscape that requires multidisciplinary coordination between developers, growers, and policy makers.

This introduction frames the report's analytical focus: understanding how product innovation, application specificity, and platform choice are unlocking both near-term field-level improvements and longer-term shifts in supply chain structure. It highlights the imperative for industry participants to adopt integrated strategies that combine robust R&D pipelines with pragmatic deployment plans, stakeholder engagement, and adaptive risk management. The objective is to equip decision-makers with the context and clarity to prioritize investments and partnerships that yield measurable agronomic and environmental benefits while navigating compliance and market acceptance dynamics.

Identifying the pivotal shifts in technology adoption, commercialization models, and delivery systems that are redefining agricultural synthetic biology value chains

The landscape for agricultural synthetic biology is undergoing transformative shifts that span technology maturation, commercialization models, and ecosystem integration. Technology platforms such as precise gene editing, modular synthetic pathways, and targeted RNA interference are moving from laboratory demonstrations to field-validated products, which in turn changes incumbent procurement and deployment practices. Developers are converging engineering rigor with agronomic validation, fostering collaborations between biotech firms, seed companies, and large-scale growers to fast-track adoption while maintaining agronomic performance.

Concurrently, formulation science and delivery systems have advanced, enabling encapsulated and liquid biologics to achieve improved shelf life, targeted release, and compatibility with existing agronomic inputs. Investment patterns are shifting from single-product bets to platform-oriented portfolios that prioritize scalable manufacturing and regulatory traceability. These shifts also precipitate new partnerships between startups and established agricultural suppliers, creating hybrid go-to-market approaches that combine agility with channel reach. As a result, the sector is increasingly defined by systems-level integration rather than isolated product innovation, and by the need to demonstrate both field efficacy and supply-chain viability.

Assessing how the cumulative tariff measures introduced in the United States during 2025 have reshaped supply chains, collaboration dynamics, and commercialization pathways in agricultural synthetic biology

Recent tariff policies implemented by the United States in 2025 have introduced additional frictions across international inputs, collaborative research, and cross-border commercialization relevant to agricultural synthetic biology. Tariffs on feedstocks, bioprocessing equipment, and certain intermediate goods have increased procurement complexity for manufacturers that rely on global supply chains for enzymes, bioreactors, and formulation components. This has prompted supply chain actors to reassess sourcing strategies, prioritize nearshoring where feasible, and evaluate inventory buffering practices to maintain production continuity.

The cumulative impacts extend to collaborative research and licensing arrangements, where higher transaction costs can slow the movement of materials and technology between partners. Regulatory compliance and customs clearance have become more salient considerations, increasing the administrative burden on companies engaging in international field trials or multi-jurisdictional product registrations. In response, some organizations have accelerated diversification of supplier bases, intensified local supplier development efforts, and reconfigured manufacturing footprints to reduce exposure. For stakeholders, the imperative is to integrate tariff risk assessment into commercial planning and to pursue contractual protections and supply continuity mechanisms that preserve R&D momentum and market access.

Uncovering segmentation-driven strategy imperatives across product classes, application domains, technology platforms, end-users, and formulation choices to guide investment and commercialization decisions

Segmentation-driven insights reveal how product, application, technology, end-user, and formulation distinctions materially influence development priorities and commercialization strategies in agricultural synthetic biology. Based on Product Type, stakeholders must differentiate between Biofertilizers-encompassing Nitrogen Fixing, Phosphate Solubilizing, and Potassium Mobilizing strains-and Biofuels like Biodiesel and Bioethanol, as well as Biomaterials such as Biofilms and Bioplastics, Biopesticides spanning Biochemical, Microbials, and RNAi-based approaches, and Enzymes including Amylases, Cellulases, and Proteases. Each product class exhibits distinct R&D timelines, regulatory touchpoints, and distribution channels, which necessitates tailored go-to-market plans.

Based on Application Area, the focus ranges from Animal Health where Probiotics and Therapeutic Proteins address productivity and disease management, to Crop Protection targeting Disease Control, Insect Control, and Weed Control, as well as Growth Enhancement efforts emphasizing Root Development, Stress Tolerance, and Yield Improvement, and Soil Remediation activities focused on Heavy Metal Removal and Organic Pollutant Degradation. These application domains determine validation protocols, end-user adoption incentives, and environmental monitoring requirements. Based on Technology Platform, choices among Crispr/Cas variants such as Base Editing, Cas12, and Cas9, Metabolic Engineering techniques including Flux Analysis and Pathway Optimization, RNAi Interference approaches like miRNA and siRNA, and Synthetic Pathways methods such as Modular Biosynthesis and Pathway Assembly create differing IP considerations and development bottlenecks. Based on End User, the market navigates the needs of Agri Biotech Companies that range from Established firms to Startups, Commercial Farmers from Large Scale operators to Smallholder systems, and Research Institutions spanning Government Labs and Universities, each with unique procurement cycles and validation expectations. Based on Formulation, product performance is affected by Encapsulated formats including Microencapsulation and Nanoencapsulation, Liquid presentations as Aqueous or Emulsions, and Powder types such as Dry Granules and Wettable Powders, which influence logistics, on-farm handling, and application compatibility. Integrating these segmentation lenses clarifies where investment in analytics, regulatory strategy, and commercial partnerships will yield the most durable competitive advantage.

Mapping how regional regulatory dynamics, industrial capabilities, and agricultural priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and commercialization pathways

Regional insights illuminate how demand drivers, regulatory frameworks, and industrial capabilities vary across geographies and shape strategic priorities for developers and investors. In the Americas, mature agricultural supply chains and active private investment communities favor rapid piloting and commercialization of biologics, supported by substantial capacity in fermentation, enzyme production, and precision application technologies. Policy discourse and state-level incentives also influence adoption pathways, with varied acceptance for gene-edited solutions and an emphasis on integrating sustainability metrics into procurement.

In Europe, Middle East & Africa, regulatory rigor and consumer scrutiny around genetically modified and gene-edited agricultural products require careful engagement and transparent risk communication. Europe's regulatory frameworks and sustainability goals encourage solutions that demonstrate reduced chemical inputs and measurable environmental benefits, while parts of the Middle East and Africa present opportunities for resilience-focused interventions such as drought tolerance and soil remediation where climatic pressures are acute. In the Asia-Pacific region, dense food systems, diverse farm scales, and strong manufacturing ecosystems create a dynamic environment for both high-throughput product development and rapid adoption in commercial farming contexts. Governments across the region frequently support biotechnology innovation through funding and public-private partnerships, and proximity to large production clusters offers advantages for scaling manufacturing and distribution.

Examining how platform specialization, commercialization partnerships, and manufacturing scale-up create differentiated competitive advantages among companies in agricultural synthetic biology

Company-level dynamics in agricultural synthetic biology reflect a mix of platform specialists, vertically integrated incumbents, and agile startups that bridge discovery and field execution. Leading players emphasize modular technology stacks that enable rapid iteration across product pipelines, while newer entrants often concentrate on narrow, high-impact use cases to validate efficacy and build market traction. Strategic alliances between product developers and distribution-focused agricultural suppliers accelerate market entry by leveraging established channels and grower relationships.

Investment in manufacturing scalability and formulation R&D distinguishes companies that move beyond proof-of-concept toward reliable field deployment. Those that integrate regulatory strategy early, maintain transparent safety dossiers, and build robust stewardship programs tend to achieve broader acceptance among commercial farmers and institutional buyers. Intellectual property approaches vary from broad platform patents to focused trade secrets around strain engineering and encapsulation processes. The competitive landscape favors organizations that balance technical depth with pragmatic commercialization capabilities, and that invest in on-farm demonstration trials and multi-year agronomic datasets to reduce perceived adoption risk.

Prioritize regulatory foresight, formulation-led product design, strategic partnerships, and supply chain resilience to accelerate adoption and reduce commercialization risk in synthetic biology

Industry leaders should adopt a set of actionable priorities that align R&D, regulatory planning, and commercial execution to accelerate adoption and mitigate risk. First, embed regulatory and stewardship considerations at the outset of product development to shorten review timelines and build market trust. Early engagement with regulators and transparent environmental monitoring plans improve the credibility of field trials and ease later registration pathways. Second, pursue formulation innovation in parallel with strain or molecule development so that delivery performance and on-farm usability inform product design rather than being treated as an afterthought.

Third, design collaborative commercialization models that combine the agility of startups with the distribution reach of established agricultural suppliers; these partnerships can reduce channel friction and enhance farmer trial uptake. Fourth, diversify supply chains and prioritize regional manufacturing capabilities to insulate operations from tariff shocks and logistics disruptions. Fifth, invest in rigorous agronomic validation through multi-environment trials and independent third-party evaluations to create defensible efficacy claims. Finally, develop clear value-communication frameworks that translate technical benefits into farm-level economics and sustainability outcomes, making it easier for procurement teams and growers to adopt novel biological solutions.

Describing a mixed-methods analytical approach integrating primary interviews, literature synthesis, patent and regulatory review, and expert validation to ensure robust insights

The research methodology underpinning this analysis combines primary qualitative inputs, secondary literature synthesis, and cross-disciplinary expert validation to produce robust, actionable insights. Primary inputs include structured interviews with technology developers, formulation scientists, agronomists, supply chain operators, and regulatory specialists. These conversations provided first-hand perspectives on development bottlenecks, field validation priorities, and commercialization constraints that informed thematic analysis across product classes and applications.

Secondary research involved systematic review of peer-reviewed literature, regulatory guidance documents, patent filings, and public corporate disclosures to triangulate technological trends and commercial behaviors. Wherever possible, the analysis prioritized primary evidence and authoritative sources, cross-checking claims to minimize bias. The findings were then validated through iterative consultations with independent subject-matter experts and practitioners who reviewed assumptions and recommended refinements. This mixed-methods approach ensured that conclusions reflect practical realities across laboratory development, formulation engineering, on-farm testing, and supply chain execution.

Concluding that integrated strategies across platform development, formulation science, regulatory engagement, and commercialization partnerships determine success in agricultural synthetic biology

The conclusion synthesizes the report's diagnostic and prescriptive strands: agricultural synthetic biology is transitioning from proof-of-concept innovation toward commercially viable solutions that require integrated strategies across technology, formulation, regulation, and market channels. Success will favor organizations that align platform capabilities with clear application needs, invest in scalable manufacturing and delivery systems, and proactively engage regulatory and farm-level stakeholders to build credibility and reduce adoption friction.

Looking forward, resilient commercialization will depend on the ability to demonstrate consistent field performance, articulate clear economic and environmental value, and to structure partnerships that bridge technical development with market access. Companies that combine rigorous agronomic validation with adaptive supply chain planning and transparent stewardship will be best positioned to capture long-term opportunities while managing operational and reputational risk. The industry's trajectory points toward systems-level solutions that integrate biological innovation into robust service models for growers, processors, and supply chain partners.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Agriculture Synthetic Biology Market, by Product Type

  • 8.1. Biofertilizers
    • 8.1.1. Nitrogen Fixing
    • 8.1.2. Phosphate Solubilizing
    • 8.1.3. Potassium Mobilizing
  • 8.2. Biofuels
    • 8.2.1. Biodiesel
    • 8.2.2. Bioethanol
  • 8.3. Biomaterials
    • 8.3.1. Biofilms
    • 8.3.2. Bioplastics
  • 8.4. Biopesticides
    • 8.4.1. Biochemical
    • 8.4.2. Microbials
    • 8.4.3. Rnai Based
  • 8.5. Enzymes
    • 8.5.1. Amylases
    • 8.5.2. Cellulases
    • 8.5.3. Proteases

9. Agriculture Synthetic Biology Market, by Technology Platform

  • 9.1. Crispr/Cas
    • 9.1.1. Base Editing
    • 9.1.2. Cas12
    • 9.1.3. Cas9
  • 9.2. Metabolic Engineering
    • 9.2.1. Flux Analysis
    • 9.2.2. Pathway Optimization
  • 9.3. Rnai Interference
    • 9.3.1. Mirna
    • 9.3.2. Sirna
  • 9.4. Synthetic Pathways
    • 9.4.1. Modular Biosynthesis
    • 9.4.2. Pathway Assembly

10. Agriculture Synthetic Biology Market, by Formulation

  • 10.1. Encapsulated
    • 10.1.1. Microencapsulation
    • 10.1.2. Nanoencapsulation
  • 10.2. Liquid
    • 10.2.1. Aqueous
    • 10.2.2. Emulsions
  • 10.3. Powder
    • 10.3.1. Dry Granules
    • 10.3.2. Wettable Powders

11. Agriculture Synthetic Biology Market, by Application Area

  • 11.1. Animal Health
    • 11.1.1. Probiotics
    • 11.1.2. Therapeutic Proteins
  • 11.2. Crop Protection
    • 11.2.1. Disease Control
    • 11.2.2. Insect Control
    • 11.2.3. Weed Control
  • 11.3. Growth Enhancement
    • 11.3.1. Root Development
    • 11.3.2. Stress Tolerance
    • 11.3.3. Yield Improvement
  • 11.4. Soil Remediation
    • 11.4.1. Heavy Metal Removal
    • 11.4.2. Organic Pollutant Degradation

12. Agriculture Synthetic Biology Market, by End User

  • 12.1. Agri Biotech Companies
    • 12.1.1. Established
    • 12.1.2. Startups
  • 12.2. Commercial Farmers
    • 12.2.1. Large Scale
    • 12.2.2. Smallholder
  • 12.3. Research Institutions
    • 12.3.1. Government Labs
    • 12.3.2. University

13. Agriculture Synthetic Biology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Agriculture Synthetic Biology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Agriculture Synthetic Biology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Agriculture Synthetic Biology Market

17. China Agriculture Synthetic Biology Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AgBiome, Inc.
  • 18.6. Agragene, Inc.
  • 18.7. Arzeda Corporation
  • 18.8. BASF SE
  • 18.9. Bayer AG
  • 18.10. Benson Hill, Inc.
  • 18.11. BioConsortia, Inc.
  • 18.12. Calysta, Inc.
  • 18.13. Caribou Biosciences, Inc.
  • 18.14. Conagen Inc.
  • 18.15. Corteva, Inc.
  • 18.16. DuPont de Nemours, Inc.
  • 18.17. EVOLVE Biosystems, Inc.
  • 18.18. Ginkgo Bioworks, Inc.
  • 18.19. Inari Agriculture, Inc.
  • 18.20. Indigo Agriculture, Inc.
  • 18.21. KWS SAAT SE & Co. KGaA
  • 18.22. Limagrain Group
  • 18.23. Pairwise Companies, Inc.
  • 18.24. Pivot Bio, Inc.
  • 18.25. Syngenta AG
  • 18.26. Synthace Ltd.
  • 18.27. Zymergen Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY NITROGEN FIXING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY NITROGEN FIXING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY NITROGEN FIXING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PHOSPHATE SOLUBILIZING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PHOSPHATE SOLUBILIZING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PHOSPHATE SOLUBILIZING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POTASSIUM MOBILIZING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POTASSIUM MOBILIZING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POTASSIUM MOBILIZING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIODIESEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIODIESEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIODIESEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOETHANOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOETHANOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOETHANOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFILMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFILMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFILMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOCHEMICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOCHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOCHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MICROBIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MICROBIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MICROBIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AMYLASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AMYLASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AMYLASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CELLULASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CELLULASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CELLULASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BASE EDITING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BASE EDITING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BASE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CAS12, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CAS12, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CAS12, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CAS9, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CAS9, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CAS9, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FLUX ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FLUX ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FLUX ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PATHWAY OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PATHWAY OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PATHWAY OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MIRNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MIRNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MIRNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SIRNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SIRNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SIRNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MODULAR BIOSYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MODULAR BIOSYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MODULAR BIOSYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PATHWAY ASSEMBLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PATHWAY ASSEMBLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PATHWAY ASSEMBLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MICROENCAPSULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MICROENCAPSULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MICROENCAPSULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY NANOENCAPSULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY NANOENCAPSULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY NANOENCAPSULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AQUEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AQUEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AQUEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY EMULSIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY EMULSIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY EMULSIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY DRY GRANULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY DRY GRANULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY DRY GRANULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY WETTABLE POWDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY WETTABLE POWDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY WETTABLE POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY THERAPEUTIC PROTEINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY THERAPEUTIC PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY THERAPEUTIC PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY DISEASE CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY DISEASE CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY DISEASE CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY INSECT CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY INSECT CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY INSECT CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY WEED CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY WEED CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY WEED CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ROOT DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ROOT DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ROOT DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY STRESS TOLERANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY STRESS TOLERANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY STRESS TOLERANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY YIELD IMPROVEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY YIELD IMPROVEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY YIELD IMPROVEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY HEAVY METAL REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY HEAVY METAL REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY HEAVY METAL REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ORGANIC POLLUTANT DEGRADATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ORGANIC POLLUTANT DEGRADATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ORGANIC POLLUTANT DEGRADATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ESTABLISHED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ESTABLISHED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ESTABLISHED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY STARTUPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY STARTUPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY STARTUPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LARGE SCALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LARGE SCALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LARGE SCALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SMALLHOLDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SMALLHOLDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SMALLHOLDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GOVERNMENT LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GOVERNMENT LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GOVERNMENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY UNIVERSITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY UNIVERSITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY UNIVERSITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 217. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, 2018-2032 (USD MILLION)
  • TABLE 219. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, 2018-2032 (USD MILLION)
  • TABLE 220. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 221. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, 2018-2032 (USD MILLION)
  • TABLE 222. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 223. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 224. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, 2018-2032 (USD MILLION)
  • TABLE 225. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 226. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, 2018-2032 (USD MILLION)
  • TABLE 227. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, 2018-2032 (USD MILLION)
  • TABLE 228. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 229. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, 2018-2032 (USD MILLION)
  • TABLE 230. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 231. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 232. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 233. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 234. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 235. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 236. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, 2018-2032 (USD MILLION)
  • TABLE 237. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 239. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, 2018-2032 (USD MILLION)
  • TABLE 240. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, 2018-2032 (USD MILLION)
  • TABLE 244. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, 2018-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 246. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 254. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, 2018-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 256. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 258. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 260. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, 2018-2032 (USD MILLION)
  • TABLE 262. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 264. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, 2018-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
  • TABLE 266. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, 2018-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, 2018-2032 (USD MILLION)
  • TABLE 270. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, 2018-2032 (USD MILLION)
  • TABLE 272. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 274. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, 2018-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 276. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, 2018-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, 2018-2032 (USD MILLION)
  • TABLE 278. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, 2018-2032 (USD MILLION)
  • TABLE 280. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 282. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 284. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 286. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, 2018-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, 2018-2032 (USD MILLION)
  • TABLE 290. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA AGRICULTURE SYNTHETIC BIOLOG